END-STAGE LIVER DISEASE
Clinical trials for END-STAGE LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new END-STAGE LIVER DISEASE trials appear
Sign up with your email to follow new studies for END-STAGE LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New registry monitors liver transplant device in thousands of patients
Disease control ENROLLING_BY_INVITATIONThis study is a registry that collects information from up to 5,000 people who received a liver transplant after the donated liver was treated with the VitaSmart HOPE system. The device keeps the liver cool and oxygenated before transplant. The goal is to see how well the device …
Matched conditions: END-STAGE LIVER DISEASE
Sponsor: Bridge to Life Ltd. • Aim: Disease control
Last updated Jun 16, 2026 23:37 UTC
-
Can smartphones keep liver transplant patients alive longer?
Disease control OngoingThis study tests whether smartphone tools, hospital resources, and caregiver support can help liver transplant recipients take their medications correctly. About 360 adults who recently received a liver transplant will participate across three centers. The goal is to improve medi…
Matched conditions: END-STAGE LIVER DISEASE
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Vitamin e compound tested to halt liver failure
Disease control OngoingThis study tests whether a supplement called tocotrienol (a form of vitamin E) can slow the worsening of end-stage liver disease in 70 adults with cirrhosis. Participants take either the supplement or a placebo twice daily for 3 years. The goal is to see if it prevents the need f…
Matched conditions: END-STAGE LIVER DISEASE
Phase: PHASE2 • Sponsor: Chandan Sen • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC
-
Liver transplant patients may dodge kidney failure with simple drug infusion
Prevention ENROLLING_BY_INVITATIONThis study tests whether giving a drug called angiotensin 2 during liver transplant surgery can prevent acute kidney injury, a common and serious complication. About 30 adults with end-stage liver disease will be randomly assigned to receive either the drug plus standard care or …
Matched conditions: END-STAGE LIVER DISEASE
Phase: PHASE4 • Sponsor: University of California, Los Angeles • Aim: Prevention
Last updated Jun 12, 2026 12:03 UTC
-
Scientists track rare childhood liver diseases to unlock their secrets
Knowledge-focused TerminatedThis study follows up to 90 children and young adults with rare liver diseases caused by mitochondrial or fatty acid breakdown problems. Researchers collect health data and samples over time to learn how these diseases progress, what genetic factors are involved, and how patients…
Matched conditions: END-STAGE LIVER DISEASE
Sponsor: Arbor Research Collaborative for Health • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:25 UTC